MARKET

NUWE

NUWE

Nuwellis Inc
NASDAQ
0.5960
+0.0058
+0.98%
Closed 16:00 03/04 EST
OPEN
0.6270
PREV CLOSE
0.5902
HIGH
0.6301
LOW
0.5821
VOLUME
523.42K
TURNOVER
0
52 WEEK HIGH
8.48
52 WEEK LOW
0.3865
MARKET CAP
3.39M
P/E (TTM)
-0.0368
1D
5D
1M
3M
1Y
5Y
Notable earnings before Tuesday's open
Seeking Alpha · 10h ago
Nuwellis Q4 Earnings Preview
Seeking Alpha · 10h ago
Weekly Report: what happened at NUWE last week (0226-0301)?
Weekly Report · 15h ago
Why Freshpet Shares Are Trading Higher By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Freshpet shares gained 15.5% to $106.29 on Monday. The company reported better-than-expected fourth-quarter financial results. Akili, Inc. Shares jumped 126% after the company reported positive results from a clinical trial of an ADHD drug in Japan.
Benzinga · 02/26 18:57
Why Intuitive Machines Shares Are Trading Lower By Around 30%; Here Are 20 Stocks Moving Premarket
Intuitive Machines, Inc. Shares fell sharply in today's pre-market trading. The company's lunar lander, Odysseus, encountered a mishap during a touchdown near the moon's south pole. ZyVersa Therapeutics, Inc., and 23andMe Holding Co. Were among the stocks moving in pre- market trading.
Benzinga · 02/26 13:18
Weekly Report: what happened at NUWE last week (0219-0223)?
Weekly Report · 02/26 10:17
Nuwellis, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nuwellis, Inc. Approved equity awards effective February 20, 2024 to two individuals entering into employment with the Company. The equity awards were approved in accordance with Nasdaq Listing Rule 5635. The Company's independent directors approved the equity awards as material inducements.
Barchart · 02/20 16:06
Nuwellis to Announce Late-Breaking Clinical Data and Host Satellite Symposium at Technology and Heart Failure Therapeutics Conference
Barchart · 02/20 07:42
More
About NUWE
Nuwellis, Inc. is a medical device company. The Company is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex SmartFlow and the Aquadex FlexFlow and the Aquadex SmartFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. The Aquadex System is designed to remove excess fluid from patients suffering from fluid overload who have failed diuretic therapy. The Aquadex System consists of a console, which is a piece of equipment containing electromechanical pumps and a liquid crystal display (LCD) screen; a one-time disposable blood circuit set, which is an integrated collection of tubing, filter, sensors, and connectors that contain and deliver the blood from and back to the patient, and a disposable catheter.

Webull offers Nuwellis Inc stock information, including NASDAQ: NUWE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NUWE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NUWE stock methods without spending real money on the virtual paper trading platform.